Related Experiment Video
Updated: Aug 23, 2026

Isolation of Mesenchymal Stem Cells from Human Alveolar Periosteum and Effects of Vitamin D on Osteogenic Activity of Periosteum-derived Cells
Published on: May 4, 2018
Evidence of downregulation of matrix extracellular phosphoglycoprotein during terminal differentiation in human
H Siggelkow1, E Schmidt, B Hennies
1Department of Gastroenterology and Endocrinology, Georg-August-University, Göttingen, Germany. hsiggel@med.uni-goettingen.de
Abstract:
Matrix extracellular phosphoglycoprotein (MEPE) is an extracellular matrix protein that was first detected in tumor-induced osteomalacia (TIO). Investigations in mice revealed that MEPE is expressed in bone and teeth in a maturation-dependent manner, reaching its maximum during mineralization. However, from knockout experiments, although it has become clear that MEPE might function as a mineralization inhibitor, the exact mechanism of action is still unclear. Even less is known about the regulation of MEPE in men. Therefore, we have studied the time- and maturation-dependent expression of MEPE in two human osteoblast culture systems, the osteosarcoma cell line HOS 58 and primary trabecular osteoblasts. Cells were cultured for up to 29 days, and the influence of beta-glycerophosphate (bGP), ascorbate, transforming growth factor beta (TGF-beta), BMP-2, and dexamethasone was studied. HOS 58 cells showed no significant effect on MEPE gene expression up to 5.0 mM, but a significant inhibition was revealed at 10 and 20 mM, when osteocalcin (OC) expression was maximal. Under the same conditions, primary human osteoblasts showed no effect on MEPE gene expression. However, when cultured in the presence of 5 mM beta-glycerophosphate, ascorbate, and dexamethasone for 29 days, which are similar conditions to those described by Owen in his differentiation model in rat osteoblasts, a progressive inhibition of MEPE gene expression to 20% of the maximum was observed. Increasing osteocalcin expression indicated advancing differentiation. In conclusion, in contrast to the results in mice, when MEPE was maximally expressed during mineralization, in the human system, this factor seems to be maximally active in the proliferation and early matrix maturation phase. It was, however, strongly suppressed, associated with the mineralization phase.
Insights
Matrix extracellular phosphoglycoprotein (MEPE) expression differs between mice and humans. In humans, MEPE is active during early osteoblast development and suppressed during mineralization, unlike in mice.
Area of Science:
- Molecular Biology
- Cell Biology
- Biochemistry
Background:
- Matrix extracellular phosphoglycoprotein (MEPE) is an extracellular matrix protein initially identified in tumor-induced osteomalacia (TIO).
- MEPE expression in mice is maturation-dependent, peaking during bone and tooth mineralization, and it may act as a mineralization inhibitor, though its mechanism remains unclear.
- Limited knowledge exists regarding MEPE regulation in humans.
Purpose of the Study:
- To investigate the time- and maturation-dependent expression of MEPE in human osteoblast culture systems.
- To examine the influence of specific factors (beta-glycerophosphate, ascorbate, TGF-beta, BMP-2, dexamethasone) on MEPE expression in human osteoblasts.
Main Methods:
- Cultured human osteosarcoma (HOS 58) cells and primary human trabecular osteoblasts for up to 29 days.
- Assessed MEPE gene expression under varying conditions, including the presence of beta-glycerophosphate (bGP), ascorbate, dexamethasone, TGF-beta, and BMP-2.
- Monitored osteocalcin (OC) expression as an indicator of osteoblast differentiation and mineralization.
Main Results:
- HOS 58 cells showed MEPE gene expression inhibition only at high concentrations (10-20 mM) of bGP, coinciding with maximal osteocalcin expression.
- Primary human osteoblasts did not show significant MEPE gene expression changes with bGP alone.
- Under specific differentiation-inducing conditions (5 mM bGP, ascorbate, dexamethasone for 29 days), MEPE gene expression progressively decreased to 20% of maximum, correlating with increased osteocalcin expression, indicating suppressed MEPE during mineralization.
Conclusions:
- Contrary to mouse models, MEPE in human osteoblasts appears most active during proliferation and early matrix maturation phases.
- MEPE expression is significantly suppressed during the mineralization phase in human osteoblasts.
- These findings highlight species-specific differences in MEPE regulation and its role in bone mineralization.
Related Concept Videos
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
Role of Matrix Metalloproteases in Degradation of ECM
A...
The Extracellular Matrix
In order to maintain tissue organization, many animal cells are surrounded by structural molecules that make up the extracellular matrix (ECM). Together, the molecules in the ECM maintain the structural integrity of tissue as well as the remarkable specific properties of certain tissues.
Composition of the Extracellular Matrix
The extracellular matrix (ECM) is commonly composed of ground substance, a gel-like fluid, fibrous components, and many structurally and functionally diverse...
Osteoclasts in Bone Remodeling

